-
Study: Smartphones and tablets key to getting more clinicians to screen patients for tobacco use
NEW YORK — Smartphones and tablets may hold the key to getting more clinicians to screen patients for tobacco use and advise smokers on how to quit. Using mobile phones loaded with tobacco screening guidelines prompted nurses to ask patients about their smoking habits in 84% of clinic visits and to offer cessation counseling to 99% of smokers who expressed a willingness to kick the habit, according to a study from Columbia University School of Nursing published in Oncology Nursing Forum.
-
Teva announces availability of bioequivalent to osteoporosis treatment Evista
JERUSALEM — Teva Pharmaceuticals on Tuesday announced the introduction and availability of Raloxifene hydrochloride tablets, USP. This product is AB rated and bioequivalent to Evista tablets.
Raloxifene hydrochloride tablets, USP are indicated for the treatment and prevention of osteoporosis in postmenopausal women.
Teva was first to file, making the product eligible for 180 days of marketing exclusivity.